All Biogen Inc Sponsors for H1B Applications - 2021

Explore H1B salary data for top companies like Biogen-inc across different cities for various job titles and discover the average salaries.

Company name
Job Title
City Name
Average Salary
Biogen Inc Manager Sdtm Development And Operations Cambridge $ 143,978 / Year
Biogen Inc Assoc Scientist Iii Gene Therapy Vector Prod Purif Cambridge $ 96,778 / Year
Biogen Inc Manager Business Analysis Cambridge $ 132,299 / Year
Biogen Inc Manager Field Deployment Analytics Cambridge $ 164,856 / Year
Biogen Inc Senior Associate Scientist Protein Drug Product Development Cambridge $ 96,778 / Year
Biogen Inc Sr Engineer Deltav Recipe Lead Cambridge $ 160,426 / Year
Biogen Inc Scientist I Analytical Development Oligonucleotide Cambridge $ 106,724 / Year
Biogen Inc Real World Evid Pers Health Analytics Biostatistician Cambridge $ 164,596 / Year
Biogen Inc Manager Regulatory Cmc Device Lead Cambridge $ 133,952 / Year
Biogen Inc Principal Biostatistician Cambridge $ 137,447 / Year
Biogen Inc Sr Applications Administrator Cambridge $ 129,316 / Year
Biogen Inc Sr It Developerengineer Cambridge $ 138,663 / Year
Biogen Inc Sr Scientist Clinical Pharmacology Cambridge $ 152,803 / Year
Biogen Inc Associate Director Strategic Pricing Contracting Cambridge $ 203,105 / Year
Biogen Inc Sr Scientist Discovery Toxicology Cambridge $ 151,000 / Year
Biogen Inc Scientist I Proteomics Cambridge $ 119,610 / Year
Biogen Inc Associate Director Commercial Cambridge $ 196,480 / Year
Biogen Inc Manager Customer Information Management Cambridge $ 135,959 / Year

Last 5 Years H-1B Salary Data

h1bInfo.org is an independent website that displays public disclosure data in a user-friendly format. We have analyzed 10 years of H1B data from USCIS and the US Department of Labor, covering more than 6 million records from FY 2014 to FY 2023. However, for the latest and most accurate data, it's best to check the official sources directly. All content on H1BInfo is copyrighted and all rights are reserved from 2022 to 2023.